The linear process of somatic evolution.

PubWeight™: 1.66‹?› | Rank: Top 3%

🔗 View Article (PMC 299861)

Published in Proc Natl Acad Sci U S A on December 01, 2003

Authors

Martin A Nowak1, Franziska Michor, Yoh Iwasa

Author Affiliations

1: Program for Evolutionary Dynamics, Harvard University, Cambridge, MA 02138, USA. martin_nowak@harcard.edu

Articles citing this

Cancer as an evolutionary and ecological process. Nat Rev Cancer (2006) 9.33

Dissecting cancer through mathematics: from the cell to the animal model. Nat Rev Cancer (2010) 1.92

Evolutionary dynamics of tumor suppressor gene inactivation. Proc Natl Acad Sci U S A (2004) 1.61

Homeostatic competition drives tumor growth and metastasis nucleation. HFSP J (2009) 1.55

The origins and implications of intratumor heterogeneity. Cancer Prev Res (Phila) (2010) 1.55

The stem cell population of the human colon crypt: analysis via methylation patterns. PLoS Comput Biol (2007) 1.38

Cancer evolution: mathematical models and computational inference. Syst Biol (2014) 1.36

(A)symmetric stem cell replication and cancer. PLoS Comput Biol (2007) 1.36

Animal cell differentiation patterns suppress somatic evolution. PLoS Comput Biol (2007) 1.19

Symmetric vs. asymmetric stem cell divisions: an adaptation against cancer? PLoS One (2013) 1.18

The age incidence of chronic myeloid leukemia can be explained by a one-mutation model. Proc Natl Acad Sci U S A (2006) 1.17

Advances for studying clonal evolution in cancer. Cancer Lett (2013) 1.14

Models of carcinogenesis: an overview. Carcinogenesis (2010) 1.05

Computational complexity of ecological and evolutionary spatial dynamics. Proc Natl Acad Sci U S A (2015) 1.04

Cancer: Risk factors and random chances. Nature (2015) 0.99

Universality of fixation probabilities in randomly structured populations. Sci Rep (2014) 0.98

Evolution of ruminant headgear: a review. Proc Biol Sci (2011) 0.97

Cancer stem cells as 'units of selection'. Evol Appl (2012) 0.94

Evolution of testicular architecture in the Drosophilidae: a role for sperm length. BMC Evol Biol (2008) 0.94

The effect of one additional driver mutation on tumor progression. Evol Appl (2012) 0.90

Cancer models, genomic instability and somatic cellular Darwinian evolution. Biol Direct (2010) 0.90

A review of spatial computational models for multi-cellular systems, with regard to intestinal crypts and colorectal cancer development. J Math Biol (2012) 0.90

The molecular clock of neutral evolution can be accelerated or slowed by asymmetric spatial structure. PLoS Comput Biol (2015) 0.89

Most Undirected Random Graphs Are Amplifiers of Selection for Birth-Death Dynamics, but Suppressors of Selection for Death-Birth Dynamics. PLoS Comput Biol (2015) 0.89

Counterintuitive properties of the fixation time in network-structured populations. J R Soc Interface (2014) 0.86

Quantifying Clonal and Subclonal Passenger Mutations in Cancer Evolution. PLoS Comput Biol (2016) 0.86

Multifocality and recurrence risk: a quantitative model of field cancerization. J Theor Biol (2014) 0.84

Should tissue structure suppress or amplify selection to minimize cancer risk? Biol Direct (2016) 0.84

Effect of dedifferentiation on time to mutation acquisition in stem cell-driven cancers. PLoS Comput Biol (2014) 0.83

A new model of time scheme for progression of colorectal cancer. BMC Syst Biol (2014) 0.82

An evolutionary explanation for the presence of cancer nonstem cells in neoplasms. Evol Appl (2012) 0.82

Patterns of proliferative activity in the colonic crypt determine crypt stability and rates of somatic evolution. PLoS Comput Biol (2013) 0.80

Evolutionary dynamics of chronic myeloid leukemia. Genes Cancer (2010) 0.80

A mathematical-biological joint effort to investigate the tumor-initiating ability of Cancer Stem Cells. PLoS One (2014) 0.79

Algorithmic methods to infer the evolutionary trajectories in cancer progression. Proc Natl Acad Sci U S A (2016) 0.79

Chromosomal instability and human cancer. Philos Trans R Soc Lond B Biol Sci (2005) 0.79

Evolutionary shift dynamics on a cycle. J Theor Biol (2012) 0.78

Cooperation with both synergistic and local interactions can be worse than each alone. Sci Rep (2014) 0.77

Hierarchical tissue organization as a general mechanism to limit the accumulation of somatic mutations. Nat Commun (2017) 0.75

Evolutionary dynamics on any population structure. Nature (2017) 0.75

The role of cell location and spatial gradients in the evolutionary dynamics of colon and intestinal crypts. Biol Direct (2016) 0.75

Cellular cooperation with shift updating and repulsion. Sci Rep (2015) 0.75

An exactly solvable, spatial model of mutation accumulation in cancer. Sci Rep (2016) 0.75

The role of backward cell migration in two-hit mutants' production in the stem cell niche. PLoS One (2017) 0.75

Articles cited by this

Stem cells, cancer, and cancer stem cells. Nature (2001) 50.27

Evolutionary rate at the molecular level. Nature (1968) 33.15

Genetic instabilities in human cancers. Nature (1998) 22.76

Genetic instability in colorectal cancers. Nature (1997) 12.51

Mutation selection and the natural history of cancer. Nature (1975) 9.73

Tumor suppressor genes. Science (1991) 5.72

Two genetic hits (more or less) to cancer. Nat Rev Cancer (2001) 5.19

A mutator phenotype in cancer. Cancer Res (2001) 4.41

Antioncogenes and human cancer. Proc Natl Acad Sci U S A (1993) 4.09

The role of chromosomal instability in tumor initiation. Proc Natl Acad Sci U S A (2002) 3.46

The tumor suppressor genes. Annu Rev Biochem (1993) 3.12

The mutation rate and cancer. Proc Natl Acad Sci U S A (1996) 2.73

Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines. Cancer Res (1995) 2.35

Stem-cell organization in mouse small intestine. Proc Biol Sci (1990) 1.93

Somatic stem cells and the kinetics of mutagenesis and carcinogenesis. Proc Natl Acad Sci U S A (2002) 1.90

Dynamics of genetic instability in sporadic and familial colorectal cancer. Cancer Biol Ther (2003) 1.89

Clonal basis of mammalian differentiation. Symp Soc Exp Biol (1971) 1.60

Epidermal stem cells. J Pathol (2002) 1.54

Somatic selection for and against cancer. J Theor Biol (2003) 1.05

Local regulation of homeostasis favors chromosomal instability. Curr Biol (2003) 1.02

Epidermal cell lineage. Biochem Cell Biol (1998) 0.97

Malignancy vs. normal differentiation of stem cells as analyzed in genetically mosaic animals. Adv Pathobiol (1977) 0.89

Articles by these authors

Dynamics of chronic myeloid leukaemia. Nature (2005) 6.63

A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. Nature (2011) 5.78

Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modeling. Sci Transl Med (2011) 4.91

Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. J Clin Invest (2010) 4.22

Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response. J Exp Med (2004) 3.48

Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell (2012) 3.39

Epidermal growth factor receptor tyrosine kinase inhibitor-resistant disease. J Clin Oncol (2013) 2.90

How should we define goodness?--reputation dynamics in indirect reciprocity. J Theor Biol (2004) 2.81

Dynamics of cancer progression. Nat Rev Cancer (2004) 2.64

DNA replication timing and long-range DNA interactions predict mutational landscapes of cancer genomes. Nat Biotechnol (2011) 2.62

Synergy and discounting of cooperation in social dilemmas. J Theor Biol (2005) 2.49

Stochastic tunnels in evolutionary dynamics. Genetics (2004) 2.42

Evolution of resistance during clonal expansion. Genetics (2006) 2.36

The leading eight: social norms that can maintain cooperation by indirect reciprocity. J Theor Biol (2005) 2.26

Evolutionary pathways in BRCA1-associated breast tumors. Cancer Discov (2012) 2.01

Genetic and phenotypic diversity in breast tumor metastases. Cancer Res (2014) 1.96

A mathematical framework to determine the temporal sequence of somatic genetic events in cancer. Proc Natl Acad Sci U S A (2010) 1.81

Successful therapy must eradicate cancer stem cells. Stem Cells (2006) 1.78

The coevolution of altruism and punishment: role of the selfish punisher. J Theor Biol (2005) 1.78

Evolutionary dynamics of invasion and escape. J Theor Biol (2004) 1.78

Can chromosomal instability initiate tumorigenesis? Semin Cancer Biol (2005) 1.77

Indirect reciprocity provides only a narrow margin of efficiency for costly punishment. Nature (2009) 1.70

Variability in DNA methylation defines novel epigenetic subgroups of DLBCL associated with different clinical outcomes. Blood (2014) 1.64

Evolutionary dynamics of tumor suppressor gene inactivation. Proc Natl Acad Sci U S A (2004) 1.61

DNA secondary structures and epigenetic determinants of cancer genome evolution. Nat Struct Mol Biol (2011) 1.56

The evolution of two mutations during clonal expansion. Genetics (2007) 1.52

Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer. Clin Cancer Res (2012) 1.51

Aberration in DNA methylation in B-cell lymphomas has a complex origin and increases with disease severity. PLoS Genet (2013) 1.50

Dynamics of colorectal cancer. Semin Cancer Biol (2005) 1.50

Evolution of resistance to targeted anti-cancer therapies during continuous and pulsed administration strategies. PLoS Comput Biol (2009) 1.43

Evolutionary theory of cancer. Ann N Y Acad Sci (2009) 1.41

Global analyses of evolutionary dynamics and exhaustive search for social norms that maintain cooperation by reputation. J Theor Biol (2006) 1.41

DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation. Blood (2011) 1.40

Evolutionary dynamics of escape from biomedical intervention. Proc Biol Sci (2003) 1.38

(A)symmetric stem cell replication and cancer. PLoS Comput Biol (2007) 1.36

A physical sciences network characterization of non-tumorigenic and metastatic cells. Sci Rep (2013) 1.33

Fitness conferred by BCR-ABL kinase domain mutations determines the risk of pre-existing resistance in chronic myeloid leukemia. PLoS One (2011) 1.32

Intratumor heterogeneity in evolutionary models of tumor progression. Genetics (2011) 1.31

DNA replication timing and higher-order nuclear organization determine single-nucleotide substitution patterns in cancer genomes. Nat Commun (2013) 1.30

Population genetics of tumor suppressor genes. J Theor Biol (2004) 1.27

Genetic addiction: selfish gene's strategy for symbiosis in the genome. Genetics (2005) 1.27

Linear model of colon cancer initiation. Cell Cycle (2004) 1.26

Evolution of the cancer genome. Trends Genet (2012) 1.22

Effects of pharmacokinetic processes and varied dosing schedules on the dynamics of acquired resistance to erlotinib in EGFR-mutant lung cancer. J Thorac Oncol (2012) 1.22

The age incidence of chronic myeloid leukemia can be explained by a one-mutation model. Proc Natl Acad Sci U S A (2006) 1.17

Evolution of resistance to cancer therapy. Curr Pharm Des (2006) 1.17

Stochastic elimination of cancer cells. Proc Biol Sci (2003) 1.16

Evolution of resistance to anti-cancer therapy during general dosing schedules. J Theor Biol (2009) 1.15

Patterns of cell division and the risk of cancer. Genetics (2003) 1.15

Comment on "Extinction debt and windows of conservation opportunity in the Brazilian Amazon". Science (2013) 1.14

Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics. Cell Stem Cell (2013) 1.14

Evolutionary dynamics of intratumor heterogeneity. PLoS One (2011) 1.14

A progenitor cell origin of myeloid malignancies. Proc Natl Acad Sci U S A (2009) 1.12

A model for the circadian rhythm of cyanobacteria that maintains oscillation without gene expression. Biophys J (2006) 1.10

Evolutionary modeling of combination treatment strategies to overcome resistance to tyrosine kinase inhibitors in non-small cell lung cancer. Mol Pharm (2011) 1.10

Neutral theory as a predictor of avifaunal extinctions after habitat loss. Proc Natl Acad Sci U S A (2011) 1.08

A mathematical methodology for determining the temporal order of pathway alterations arising during gliomagenesis. PLoS Comput Biol (2012) 1.07

Stochastic dynamics of metastasis formation. J Theor Biol (2005) 1.07

Saturation of enzyme kinetics in circadian clock models. J Biol Rhythms (2002) 1.05

Evolutionary dynamics of tumor progression with random fitness values. Theor Popul Biol (2010) 1.05

Somatic selection for and against cancer. J Theor Biol (2003) 1.05

Stripes, spots, or reversed spots in two-dimensional Turing systems. J Theor Biol (2003) 1.05

Dynamics of metastasis suppressor gene inactivation. J Theor Biol (2006) 1.04

Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib. PLoS Comput Biol (2009) 1.04

Comparative study of circadian clock models, in search of processes promoting oscillation. J Theor Biol (2002) 1.04

The pace of evolution across fitness valleys. J Theor Biol (2009) 1.04

Next-generation sequencing of paired tyrosine kinase inhibitor-sensitive and -resistant EGFR mutant lung cancer cell lines identifies spectrum of DNA changes associated with drug resistance. Genome Res (2013) 1.03

The evolution of a Müllerian mimic in a spatially distributed community. J Theor Biol (2005) 1.02

Local regulation of homeostasis favors chromosomal instability. Curr Biol (2003) 1.02

Genetic instability and clonal expansion. J Theor Biol (2006) 1.00

How canalization can make loops: a new model of reticulated leaf vascular pattern formation. J Theor Biol (2006) 1.00

The therapeutic implications of plasticity of the cancer stem cell phenotype. PLoS One (2010) 0.99

Evolution towards oscillation or stability in a predator-prey system. Proc Biol Sci (2010) 0.99

Dynamics of chronic myeloid leukemia response to long-term targeted therapy reveal treatment effects on leukemic stem cells. Blood (2011) 0.98

A differentiation-based phylogeny of cancer subtypes. PLoS Comput Biol (2010) 0.98

A differentiation-based microRNA signature identifies leiomyosarcoma as a mesenchymal stem cell-related malignancy. Am J Pathol (2010) 0.97

Optimal growth pattern of defensive organs: the diversity of shell growth among mollusks. Am Nat (2004) 0.95

A symmetry of fixation times in evoultionary dynamics. J Theor Biol (2006) 0.95

FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder. Cancer Med (2014) 0.95

Coupled ecological-social dynamics in a forested landscape: spatial interactions and information flow. J Theor Biol (2007) 0.94

Genetic instability and the quasispecies model. J Theor Biol (2006) 0.94

The emergence of tumor metastases. Cancer Biol Ther (2007) 0.93

Temperature compensation in circadian clock models. J Theor Biol (2004) 0.93

The evolution of tumor metastases during clonal expansion. J Theor Biol (2009) 0.93

Growth based morphogenesis of vertebrate limb bud. Bull Math Biol (2008) 0.93

Mechanisms for split localization of Fgf10 expression in early lung development. Dev Dyn (2009) 0.93

Unique coevolutionary dynamics in a predator-prey system. J Theor Biol (2011) 0.93

Traveling wave formation in vertebrate segmentation. J Theor Biol (2009) 0.92

Single-class orbits in nonlinear Leslie matrix models for semelparous populations. J Math Biol (2007) 0.92

Stochastic dynamics of cancer initiation. Phys Biol (2011) 0.91

Sexual selection can increase the effect of random genetic drift--a quantitative genetic model of polymorphism in Oophaga pumilio, the strawberry poison-dart frog. Evolution (2009) 0.91

Direction of regeneration waves in grid-based models for forest dynamics. J Theor Biol (2006) 0.90

Integrative analysis of 1q23.3 copy-number gain in metastatic urothelial carcinoma. Clin Cancer Res (2014) 0.90

Directionality of stripes formed by anisotropic reaction-diffusion models. J Theor Biol (2002) 0.89

A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1). Haematologica (2008) 0.89

Selection pressure exerted by imatinib therapy leads to disparate outcomes of imatinib discontinuation trials. Haematologica (2012) 0.89

Optimal defense strategy: storage vs. new production. J Theor Biol (2002) 0.88